Patient-controlled analgesic infusions: alfentanil versus morphine

Pain

Volumn 49, Issue 3, 1992, Pages 301-310

  Hill, Harlan F ^a   Coda, Barbara A ^a,b   Mackie, Adam M ^b   Iverson, Karen ^a  

^a FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Alfentanil; Morphine; Oral mucositis pain; Patient controlled analgesia; Pharmacokinetics, opioids

Indexed keywords

ALFENTANIL; MORPHINE;

ADULT; ARTICLE; CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; NAUSEA; PAIN; PRIORITY JOURNAL; SEDATION; SIDE EFFECT;

ADULT; ALFENTANIL; ANALGESIA, PATIENT-CONTROLLED; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MORPHINE; MOUTH MUCOSA; NEOPLASMS; PAIN, INTRACTABLE; STOMATITIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026663564     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(92)90235-4     Document Type: Article

References (51)

1. An information criterion (AIC).
2. Ventilatory effects during and after continuous infusion of fentanyl or alfentanil
3. An evaluation of the accuracy of pharmacokinetic data for the computer-assisted infusion of alfentanil
4. Comparison of a computer-assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery
5. Comparison of fentanyl, sufentanil and alfentanil anesthesia in patients undergoing valvular heart surgery
6. The comparative pharmacokinetics of fentanyl and alfentanil
7. Pharmacokenetics of alfentanil in man
8. Chemoradiotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea
9. Patient-controlled analgesic therapy. Part IV. Pharmacokinetics and analgesic plasma concentrations of morphine
10. Pharmacokinetic model-driven infusion of fentanyl: assessment of accuracy
11. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer
12. Potential analgesic contribution from morphine-6-glucuronide in CSF
13. The metabolism and bioavailability of morphine in patients with severe liver cirrhosis
14. Pharmacokinetic tailoring of computer-controlled alfentanil infusions
15. Patient-controlled analgesia after bone marrow transplantation for cancer
16. Dose effects of alfentanil in human analgesia
17. Self-administration of morphine in bone marrow transplant patients reduces drug requirement
18. Steady-state infusions of opioids in human. II. Concentration-effect relationships and therapeutic margins
19. Steady-state infusions of opioids in human volunteers. I. Pharmacokinetic tailoring
20. A computerbased system for controlling plasma opioid concentrations according to patient need
21. Patient-controlled analgesic administration: comparison of steady-state morphine infusions to bolus doses
22. MLAB — a mathematical modeling tool
23. Patient-controlled intravenous analgesia for postoperative pain relief
24. Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients
25. Evaluating the accuracy of using population pharmacokinetic data to predict plasma concentrations of alfentanil
26. AZ pharmacokinetics of fentanyl and its newer derivatives
27. Estimation of pharmacokinetic parameters: statistical considerations
28. Ventilatory depression during and after infusion of alfentanil in man
29. Morphine-6-glucuronide, a potent mu agonist
30. Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration
31. Opiate receptor binding-effect relationship: sufentanil and etorphine produce analgesia at the μ-site with low fractional receptor occupancy
32. Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation
33. Ventilatory and mental effects of alfentanil and fentanyl
34. A consideration of labor pain and patient-controlled technique for its relief with meperidine
35. EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil
36. Pharmacokinetics, pharmacodynamics dand rational opioid selection
37. Some suggestions for measuring predictive performance
38. Differential cross-tolerance between intrathecal morphine and sufentanil in the rat
39. Kinetics of intravenous and intramuscular morphine
40. Alfentanil a kinetically predictable narcotic analgesic (editorial)
41. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion
42. Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord
43. Determination of morphine in cerebrospinal fluid and plasma by high performance liquid chromatography with electrochemical detection
44. Comparison of alfentanil with fentanyl for outpatient anesthesia
45. Commentary: a physiological approach to hepatic drug clearance
46. Rapid and sensitive gas chromatographic method for the determination of alfentanil and sufentanil in biological samples
47. Properties of the modulation of spinal nociceptive transmission by receptor-selective agents